Abstract
Hyperphosphatemic Familial Tumoral Calcinosis (HFTC; MIM211900) is a rare autosomal recessive disorder characterized by the progressive deposition of calcified masses in cutaneous and subcutaneous tissues, associated with elevated circulating levels of phosphate. The disease was initially found to result from mutations in GALNT3 encoding a glycosyltransferase. However, more recently, the S71G missense mutation in FGF23, encoding a potent phosphaturic protein, was identified in two families. In the present report, we describe a second mutation in FGF23 underlying a severe case displaying calcifications of cutaneous and numerous extracutaneous tissues. The mutation (M96T) was found to affect a highly conserved methionine residue at position 96 of the protein. These observations illustrate the extent of genetic and phenotypic heterogeneity in HFTC.
Original language | English (US) |
---|---|
Pages (from-to) | 261-266 |
Number of pages | 6 |
Journal | Human Genetics |
Volume | 118 |
Issue number | 2 |
DOIs | |
State | Published - Nov 2005 |
Externally published | Yes |
Bibliographical note
Funding Information:Ackowledgements We acknowledge the family for having participated in the present study. We are grateful to V. Friedman for DNA sequencing services. This study was supported in part by grants provided by The Israeli Ministry of Health-Chief Scientist Office and by the General Trustee Fund.
Keywords
- Calcinosis
- Extraskeletal
- FGF23
- GALNT3
- Mutation
- Phosphate